Tag: SYK inhibitor

Oscotec reports positive results from cevidoplenib phase 2 trial in ITP

businessnewstoday- February 24, 2023

Oscotec has reported positive results from the phase 2 clinical trial of its SYK inhibitor cevidoplenib in patients with immune thrombocytopenia (ITP) who did not ... Read More